- Home
- RPID vs PRQR Comparison
RPID vs PRQR Comparison
Compare RPID & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- PRQR
- Stock Information
- Founded
- RPID 2006
- PRQR 2012
- Country
- RPID United States
- PRQR Netherlands
- Employees
- RPID N/A
- PRQR N/A
- Industry
- RPID Medical Specialities
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- RPID Health Care
- PRQR Health Care
- Exchange
- RPID Nasdaq
- PRQR Nasdaq
- Market Cap
- RPID 145.1M
- PRQR 163.3M
- IPO Year
- RPID 2021
- PRQR 2014
- Fundamental
- Price
- RPID $3.33
- PRQR $1.66
- Analyst Decision
- RPID Buy
- PRQR Strong Buy
- Analyst Count
- RPID 1
- PRQR 7
- Target Price
- RPID $8.00
- PRQR $9.00
- AVG Volume (30 Days)
- RPID 163.7K
- PRQR 470.6K
- Earning Date
- RPID 05-09-2025
- PRQR 05-08-2025
- Dividend Yield
- RPID N/A
- PRQR N/A
- EPS Growth
- RPID N/A
- PRQR N/A
- EPS
- RPID N/A
- PRQR N/A
- Revenue
- RPID $29,645,000.00
- PRQR $21,212,711.00
- Revenue This Year
- RPID $18.54
- PRQR $2.87
- Revenue Next Year
- RPID $20.55
- PRQR N/A
- P/E Ratio
- RPID N/A
- PRQR N/A
- Revenue Growth
- RPID 28.36
- PRQR 85.91
- 52 Week Low
- RPID $0.58
- PRQR $1.07
- 52 Week High
- RPID $4.04
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- RPID 61.61
- PRQR 52.16
- Support Level
- RPID $3.15
- PRQR $1.66
- Resistance Level
- RPID $3.84
- PRQR $1.83
- Average True Range (ATR)
- RPID 0.27
- PRQR 0.10
- MACD
- RPID 0.02
- PRQR -0.00
- Stochastic Oscillator
- RPID 50.96
- PRQR 48.48
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.